Cited by 55Reproductive Health and ContraceptionMenstrual Health and DisordersHypothalamic control of reproductive hormones

Evaluation of extended and continuous use oral contraceptives

Open access
Johnson, Julia·2008·Therapeutics and Clinical Risk Management

Abstract

Evaluation of extended and continuous use oral contraceptives Kristen Page Wright, Julia V JohnsonUniversity of Vermont College of Medicine and Reproductive Endocrinology and Infertility, Women’s Health Care Services, Fletcher Allen Health Care, Burlington, VT USAAbstract: Oral contraceptives are classically given in a cyclic manner with 21 days of active pills followed by 7 days of placebo. In the past 4 years, new oral contraceptives have been introduced which either shorten the placebo time, lengthen the active pills (extended cycle), or provide active pills every day (continuous). These concepts are not new; extended and continuous pills were first studied in the 1960s and 1970s and have been provided in an off-label manner by gynecologists to treat menstrual disorders, such as menorrhagia and dysmenorrhea, and gynecologic disorders, such as endometriosis. Now that extended and continuous combined oral contraceptives are available for all patients, it is critical for providers to understand the physiology, dosing, side effects, and benefits of this form of oral contraceptive. This article reviews the history and the potential uses of the new continuous combined oral contraceptive.Keywords: oral contraceptives, administration, dosage, adverse effects, menstrual disturbances

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/tcrm.s2143

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Oral contraceptives are most effective when taken at approximately the same time every day.

    “(3) oral contraceptives are most effective when taken at approximately the same time every day [30].”

    From Medication Adherence Reminder System for Virtual Home Assistants: Mixed Methods Evaluation Study (2021) · cites this paper as [30]

    The Efficacy section (page unavailable) says oral contraceptives are more effective with perfect use than with typical use and identifies missed pills as a common risk. It does not say that taking a pill at approximately the same time each day, rather than at different times, improves effectiveness. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 36 · Cited by 55

Research works printed but not linked: 31

  1. Anderson FD Hait H 2003 The Seasonale-301 Study Group. A multi-center, randomized study of an extended cycle oral contraceptive Contraception 68 89 96 12954519
  2. Archer DF Jensen JT Johnson JV 2006 Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results Contraception 74 439 45 17157099
  3. Barnhart K Mirkin S Grubb GS 2006 Return of fertility after cessation of continuous oral contraceptive Fertil Steril 87 Suppl 1 S15 18462723
  4. Cachrimanidou AC Hellberg D Nilsson S 1993 Long-interval treatment regiment with a desogestrel-containing oral contraceptive Contraception 48 205 15 8222651
  5. Cachrimanidou AC Hellberg D Nilsson S 1994 Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive Contraception 50 153 65 7956214
  6. Coutinho EM O’Dwyer E Barbosa IC 1995 Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route Contraception 51 355 8 7554976
  7. Davis AR Kroll R Soltes B 2008 Occurrence of menses or pregnancy after cessation of continuous oral contraceptive Fertil Steril 89 1059 63 17658522
  8. den Tonkelaar I Oddens BJ 1999 Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use Contraception 59 357 62 10518229
  9. Edelman A Lew R Cwiak C 2007 Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women Contraception 75 450 3 17519151
  10. Edelman AB Gallo MF Jensen JT 2005 Continuous or extended cycle versus cyclic use of combined oral contraceptives for contraception Cochrane Database of Systemic Reviews 3 CD004695 16034942
  11. Edelman AB Koontz SL Nichols MD 2006 Continuous oral contraceptives: Are bleeding patterns dependent on the hormones given? Obstet Gynecol 107 657 65 16507938
  12. Gerschultz KL Sucato GS Hennon TR 2007 Extended cycling of combined hormonal contraceptives in adolescents: Physician views and prescribing practices J Adolesc Health 40 151 7 17259055
  13. Johnson JV Grubb GS Constantine GD 2007 Endometrial histology following 1 year of continuous daily regimen of levonorgestrel 90 μg/ethinyl estradiol 20 μg Contraception 75 23 6 17161119
  14. Kastner P Krust A Turcotte B 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B EMBO Journal 9 1603 14 2328727 PMC551856
  15. Kjerulff KH Erickson BA Langenberg PW 1996 Chronic gynecological conditions reported by US women: finding from the National Health Interview Survey, 1984 to 1992 Am J Public Health 86 195 9 8633735 PMC1380327
  16. Kwiecien M Edelman A Nichols M 2003 Bleeding patterns and patient acceptability of standard or continuos dosing regimens of a low-dose oral contraceptive: a randomized trial Contraception 67 9 13 12521651
  17. Loudon NB Foxwell M Potts DM 1977 Acceptability of an oral contraceptive that reduces the frequency of menstruation: The tri-cycle pill regimen BMJ 2 487 90 890363 PMC1630912
  18. Mahmood T Saridogan E Smutna S 1998 The effect of ovarian steroids on epithelial ciliary beat frequency in the human fallopian tube Hum Reprod 3 2991 4 9853843
  19. Maitra N Kulier R Bloemenkamp KWM 2008 Progestogens in combined oral contraceptives for contraception Cochrane Database of Systematic Reviews Issue 1 15266546
  20. Miller L Hughes JP 2003 Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial Obstet Gynecol 101 653 61 12681866
  21. Miller L Notter KM 2001 Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial Obstet Gynecol 98 771 8 11704167
  22. Mishell DR Kletzky OA Brenner PF 1977 The effect of contraceptive steroid on hypothalamic-pituitary function Am J Obstet Gynecol 128 60 74 403765
  23. Moyer DL Felix JC 1998 The effects of progesterone and progestins on endometrial proliferation Contraception 57 399 403 9693400
  24. Rossmanith WG Steffens D Schramm G 1997 A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity Contraception 56 23 30 9306028
  25. Schneider MB Fisher M Friedman SB 1999 Menstrual and pre-menstrual issues in female military cadets: a unique population with significant concerns J Pediatr Adolesc Gynecol 12 195 201 10584223
  26. Sitruk-Ware R 2006 New progestagens for contraceptive use Hum Reprod Update 12 169 78 16291771
  27. Speroff L DeCherney A 1993 Evaluation of new generation of oral contraceptives Obstet Gynecol 81 1034 47 8497347
  28. Sulak PJ Cressman BE Waldrop E 1997 Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms Obstet Gynecol 89 179 83 9015017
  29. Sulak PJ Kuehl TJ Ortiz M 2002 Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms Am J Obstet Gynecol 186 1142 9 12066088
  30. Trego LL 2007 Military women’s menstrual experiences and interest in menstrual suppression during deployment J Obstet Gynecol Neonatal Nurs 36 342 7 17594409
  31. Wiegratz I Hommel HH Zimmermann T 2004 Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives Contraception 69 37 42 14720618

Authors
Johnson, J.
Affiliations
University of Vermont (US)
Corresponding author
Johnson, Julia
Venue
Therapeutics and Clinical Risk Management
Published
2008-10
Volume
Volume 4
Issue
5
Pages
905-911
ISSN
  • 1176-6336 (ISSN-L)
  • 1178-203X
OpenAlex
W1934960365
Cited by
55
References
36
Citations by year
2026: 4 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 1 · 2021: 8 · 2020: 3 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 3 · 2013: 5
FWCI
1.32
Type
journal article
Language
en
Open access
Locations
  • Therapeutics and Clinical Risk Management (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship@UMassChan (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
extended-cycle oral contraceptives, continuous oral contraceptives, combined oral contraceptives, menstrual disorders, menorrhagia, dysmenorrhea, endometriosis, contraceptive side effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review